← Back to Clinical Trials
Recruiting NCT06716398

A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance Phase

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Acne
Sponsor Pierre Fabre Dermo Cosmetique
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 14 Years
Max Age 24 Years
Start Date 2024-07-03
Completion 2025-07-30
Interventions
Test productComparator product

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In this study, we are interested in the global benefit of the tested product as complementary care to a topical medical treatment during a 3 month-associated treatment phase followed by a 3 month-maintenance phase, compared to a light moisturizing cream, in teenagers and adults with acne. We also want to evaluate the tolerance of the tested product in association and in maintenance of the topical medical treatment.

Eligibility Criteria

Inclusion Criteria: * Male or Female aged between 14 and 24 years (included) * Subject with facial acne with score index severity IGA = 2 or 3, assessed on a scale ranged from 0 to 4. * Subject for whom a prescription of 12 weeks of a reference topical medical treatment is required from the day of the inclusion visit, for mild to moderate face acne Exclusion Criteria: Criteria related to the disease: * Facial skin disease other than acne, skin abnormalities, or dermatological condition on the face liable to interfere with the study assessments * Acne conglobata, Acne fulminans, nodulocystic acne or acneiform eruptions, according to investigator's assessment * Other type of pigmentation disorder than acne-related PIH liable to interfere with the study assessments according to the investigator Criteria related to treatments and/or products: \- Topical or oral treatment established or modified during the previous weeks or planned to be established or modified during the study, liable to i

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}